Name: Gliclazide Sustained-Release Tablets 30mg (Darentang) – Factory wholesale For Laboratory Research Use Only - Arizona-mall
Price: 2.00 HKD
Availability: InStock

Gliclazide Sustained-Release Tablets 30mg (Darentang) – Factory wholesale For Laboratory Research Use Only

$2.00

Gliclazide Sustained-Release Tablets (30mg) are used in laboratory research involving insulin secretion, beta-cell response, and glucose regulation in Type 2 diabetes models. Manufactured by Darentang New Xin Pharmaceutical Factory. Not for human or veterinary use.?Please consult staff for price, other specifications and uses?

Compare

描述

Gliclazide is a second-generation sulfonylurea that stimulates insulin release from pancreatic beta-cells by modulating ATP-sensitive potassium channels. The sustained-release (SR) formulation provides controlled exposure for extended biological modeling.

Each tablet delivers 30mg of gliclazide, with 15 tablets per blister and two blisters per box (30 tablets total). Manufactured by Tianjin Zhongxin Pharmaceutical Group Co., Ltd. – New Xin Pharmaceutical Factory under NMPA registration H20065582. Product code: 86900964000200.

Strictly for laboratory use only. Not approved for human or veterinary applications.

Contents hide

1 Gliclazide Sustained-Release Product Specifications

2 Gliclazide Sustained-Release Mechanism & Research Applications

3 Safety & Handling

4 Research Use Disclaimer

Gliclazide Sustained-Release Product Specifications

Parameter	Details
Product Name	Gliclazide Sustained-Release Tablets
Generic Name	Gliclazide SR
CAS Number	21187-98-4
Molecular Formula	C15H21N3O3S
Molecular Weight	323.41?g/mol
Dosage Form	Oral tablet (sustained release)
Strength	30mg per tablet
Quantity	15 tablets × 2 blisters (30 tablets per box)
Approval Number	H20065582 (China NMPA)
Product Code	86900964000200
Manufacturer	Tianjin Zhongxin Pharmaceutical (Darentang New Xin Factory)
Barcode	6941155701272
Intended Use	For laboratory research only
Storage Conditions	Store in a dry place below 25°C, avoid humidity and sunlight

Gliclazide Sustained-Release Mechanism & Research Applications

Gliclazide stimulates insulin secretion by inhibiting potassium channels in pancreatic beta cells, causing calcium influx and subsequent insulin release. It is a useful compound in studies related to:

Type 2 diabetes mellitus modeling
Glucose metabolism and insulin resistance research
Sulfonylurea receptor pharmacology
Pancreatic beta-cell functional assays
Glycemic control simulation in animal models

Safety & Handling

Use Restriction: For laboratory research use only
Protective Equipment: Gloves, lab coat, safety glasses
Storage: Store sealed below 25°C
Disposal: Dispose of via standard laboratory chemical waste procedures

Research Use Disclaimer

This product is intended solely for laboratory research. It is not approved for human, diagnostic, therapeutic, or veterinary use. Misuse may involve safety or regulatory risks. Researchers should follow proper biosafety and disposal protocols.

其他信息

重量	1 公斤
尺寸	26 × 23 × 26 厘米

评价

目前还没有评价

成为第一个“Gliclazide Sustained-Release Tablets 30mg (Darentang) – Factory wholesale For Laboratory Research Use Only” 的评价者

Q1: Can Gliclazide SR be used in clinical applications?

A1: No. This product is strictly for laboratory and experimental research purposes.

Q2: Is bulk purchasing available?

A2: Yes. We offer both wholesale and retail options. Please contact us for tiered pricing.

Q3: Are COA and SDS documents provided?

A3: Yes, Certificate of Analysis (COA) and Safety Data Sheet (SDS) are available upon request.

Q4: What research fields use this compound?

A4: Common in endocrinology, pharmacology, and preclinical diabetes research.

Q5: How is the product packaged?

A5: Each box contains 2 blister packs, 15 tablets each, 30mg per tablet.